Onsdag 30 Oktober | 09:26:34 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2025-10-22 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-04-29 - Kvartalsrapport 2025-Q1
2025-04-29 - Årsstämma
2025-02-13 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2024-05-22 - Årsstämma
2024-05-02 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-08 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-06-02 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2023-06-02 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-03-24 - Extra Bolagsstämma 2023
2023-03-08 - Bokslutskommuniké 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-10-03 - Extra Bolagsstämma 2022
2022-08-24 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning VIMIAN 0.00 SEK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-03-09 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Vimian Group är en koncern verksamma inom djurhälsa. Bolaget levererar via sina dotterbolag läkemedel och tekniska lösningar till veterinärer, laboratorier och husdjursägare. Produkterna inkluderar exempelvis läkemedel med tillhörande klinisk forskning samt digitala plattformar för veterinärkliniker. Bolaget är verksamma på en global nivå med huvudkontor i Stockholm.
2023-04-14 12:15:00

Vimian Group today announces that the board of directors, based on the authorization from the 2022 annual general meeting, has resolved on a share issue of 249,482 ordinary shares and 249,482 class C shares as part of an earn-out payment to the sellers of Kahu Vet Group in accordance with the share purchase agreement signed in February 2022.

On 3 February 2022, Vimian disclosed that it had entered into an agreement to acquire Kahu Vet Group, a supplier of veterinary surgical products in Australia and New Zealand. The acquisition was completed on 1 March 2022. In addition to an upfront payment, the agreement includes potential earn-out payments over three years, part of which is to be paid in Vimian shares. As part of a first earn-out payment, the board of directors has today, based on the authorization granted by the annual general meeting 2022, resolved to issue 249,482 ordinary shares and 249,482 class C shares to the selling management. Following the share issue, the total number of shares in Vimian Group AB will amount to a total of 457,123,694 shares comprising 437,943,556 ordinary shares and 19,180,138 class C shares, and the share capital of Vimian Group AB amounts to SEK 762325,243060.